Roche Holding (QX) Share Price - RHHBY

Best deals to access real time data!
Canna Trader Pro
Monthly Subscription
for only
US$59.99
USA Small Cap Pro
Monthly Subscription
for only
US$49.05
USA SMALL CAP BASIC
Monthly Subscription
for only
US$33.03
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Roche Holding (QX) RHHBY Other OTC Common Stock Roche Holding Ltd S/Adr
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  0.46 1.34% 34.90 34.95 34.72 34.85 34.44 01:40:43
Bid Price Ask Price Spread Spread % News
34.89 34.90 0.01 0.03% - -
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
891 304,772 US$ 34.8700 US$ 10,627,411 1,068,474 26.35 - 34.98
Last Trade Type Quantity Price Currency
01:40:43 100 US$ 34.90 USD

Roche Holding (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 30.11B 862.56M $ 10.45B - 2.88 862.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Roche Holding (QX) News

Historical RHHBY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week34.5734.9534.0834.4135358k3M2M0.330.95%
1 Month32.7934.9532.28433.7650358k3M1M2.116.43%
3 Months34.334.9531.80533.3954324k4M1M0.61.75%
6 Months31.2334.9829.4533.0810319k6M1M3.6711.75%
1 Year26.4634.9826.3531.5641287k6M1M8.4431.90%
3 Years32.27536.8225.2530.7290287k12M1M2.6258.13%
5 Years37.0438.540.00050732.1119240k12M1M-2.14-5.78%

Roche Holding (QX) Description

Headquartered in Basel, Switzerland, Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. In 2017, the Roche Group employed about 94,000 people worldwide, invested 10.4 billion Swiss francs in R&D and posted sales of 53.3 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com
Your Recent History
USOTC
RHHBY
Roche Hold..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 17:56:50